Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel DAC compression technology enhances Daptomycin purity and yield. Reduce solvent usage and scale production efficiently with our specialized purification solutions.
Advanced CeCl3-catalyzed semi-synthesis of Paclitaxel from 10-DAB. High-yield, scalable API manufacturing process reducing costs and lead times for global supply chains.
Discover the patented AIBN-initiated synthesis of Anastrozole offering superior purity and simplified purification for reliable Active Pharmaceutical Ingredients (APIs) supply chains.
Novel stereoselective synthesis of S nicotine via patent CN114276204B. Room temperature reaction ensures high purity and supply chain reliability for pharmaceutical intermediates.
Patent CN105481852B reveals novel antitumor intermediate synthesis. Enhanced purity and scalable routes offer significant supply chain and cost advantages.
Patent CN111925298B reveals a high-yield 4-CNAB preparation method. Discover cost reduction in API manufacturing and enhanced supply chain reliability for oral GLP-1 excipients.
Patent CN1322711A details a novel resolution method for Chloramphenicol. Discover cost-effective, high-purity pharmaceutical intermediate manufacturing solutions.
Patent CN107759603B reveals a high-yield Udenafil synthesis route, reducing costs and improving purity for reliable pharmaceutical intermediate suppliers.
Novel patent CN116283623B route for dextromethorphan intermediates. Enhanced yield, mild conditions, scalable manufacturing for reliable pharmaceutical supply chains.
Patent CN115197228A reveals efficient Rh-catalyzed synthesis of spiro compounds. Discover cost reduction in fine chemical manufacturing and high-purity intermediate supply solutions.
Patent CN116715715B details efficient synthesis of C20 oxime pregnane alkaloids with anti-tumor activity, offering cost-effective supply chain solutions.
Patent CN108752328B reveals a water-based Azilsartan synthesis route offering high purity and cost reduction in pharmaceutical intermediate manufacturing for global supply chains.
Patent CN107586305A reveals a novel trichloroacetic acid method for beta-lactam deprotection, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN103923058A details a safer vilanterol intermediate route avoiding toxic catalysts, offering cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Novel ionic liquid catalysis for 1,5-benzodiazepine derivatives ensures high purity and scalable production. Reliable supplier for pharmaceutical intermediates with green chemistry advantages.
Patent CN1313471C reveals mixed solvent crystallization for Mezlocillin Sodium. Enhances purity, yield, and supply chain stability for pharmaceutical manufacturing partners globally.
Patent CN102702138B details a novel adsorption and alkali treatment method for Repaglinide, achieving >99.6% purity and offering significant cost reduction in API manufacturing.
Patent CN103408639B offers advanced chromatography for 99% purity vancomycin. Reduces costs and improves supply chain reliability for antibiotic manufacturing partners globally.
Novel catalytic hydrogenation method for tranexamic acid. Reduces catalyst poisoning, improves trans-isomer ratio, ensures supply chain stability for pharmaceutical intermediates.
Advanced solid-liquid phase synthesis patent CN103102390A improves Octreotide yield and purity, offering significant cost reduction in pharmaceutical manufacturing.